November 18, 2015 — Mirada Medical Ltd has announced that its XD3 Advanced image review and analysis software is being deployed by Alliance Medical in partnership with 30 National Health Service (NHS) hospital positron emission tomography/computed tomography (PET/CT) departments nationwide.
In January 2015 the NHS selected a collaborative network, led by Alliance Medical, to provide PET/CT scanning services across the country, following a competitive tender process.
The network also involves a number of leading academic institutions, including The Christie NHS Foundation Trust and Leeds Teaching Hospitals NHS Trust, as well as local NHS and charitable partners.
PET/CT imaging is critical for accurate diagnosis, staging and follow-up of many cancers. It enables treating clinicians to see precisely where the tumors are located and how they change or spread over the course of the disease and its treatment. More than 50,000 PET/CT scans are read in England each year. Mirada's XD3 software provides powerful tools to combine quantification information from these scans, enabling clinicians to confidently assess their patients.
As part of the contract Oxford-based Mirada Medical are delivering their diagnostic imaging software, XD3 Advanced, to the whole collaborative network.
“Mirada’s XD3 software provides a robust reporting solution with state-of-the-art features facilitating quantitative data analysis. It is a reliable and efficient platform for PET/CT reporting that gives confidence in image interpretation. This is key to the assessment and treatment efficacy and effective ongoing cancer care,” said Andrew Scarsbrook, M.D., consultant radiologist and nuclear medicine physician, Leeds Teaching Hospitals NHS Trust.
“Alliance Medical believes that our PET/CT collaborative network, together with Mirada Medical software, will result in the highest quality clinical analysis combined with improvements in productivity and associated cost,” said Johann Alberts, M.D., director of PET/CT operations, Alliance Medical.
Mirada's software products are available to the NHS and to thousands of users throughout the world under its own brand, and on an OEM basis through select global leading healthcare companies.
For more information: www.mirada-medical.com
July 30, 2024 
